(3-Carbamoyl-5-nitrophenyl)boronic acid, 95.0%, 250mg

But-3-ene-1-sulfonamide, 95%, 1g

2-Chloro-4-(trifluoromethyl)benzenesulfonylchloride, 97.0%, 5g

(2E)-3-(2,5-dimethoxyphenyl)-1-(4-ethoxyphenyl)prop-2-en-1-one, 95.0%, 10g

Methyl 4-amino-3-methylbenzoate, 99.0%, 25g

6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-((S)-1-(((S)-1-((4-(hydroxymethyl)phenyl)amino)-1-oxo-5-ureidopentan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)hexanamide, 99+%, 500mg

5-(4-Hydroxypiperidin-1-yl)thiophene-2-carboxaldehyde>98.0%(GC)1g

(R)-1-(3,4-DIMETHOXYPHENYL)ETHANAMINE HCL, 95.0%, 250mg

cis-4,7-Dihydro-1,3-dioxepin, 98%, 5g

2-Chloroheptane>97.0%(GC)5mL

5-{[(tert-butoxycarbonyl)amino]methyl}-2-furoic acid, 95.0%, 250mg

2-Fluorobenzamidine hydrochloride, 95.0%, 1g

4-Bromo-3,5-difluorophenylacetic acid, 95.0%, 250mg